NEWS & PROGRESS

Thanks to generous supporters like you, the BCRFA invested $1.275 million in 24 breast cancer research projects at 7 institutes across the state in 2022.

Evaluating associations of rurality and neighborhood disadvantage with racial disparities in breast cancer mortality among women in the state of Alabama

Ritu Aneja, PhD

Predicting the Risk of Heart Failure in Breast Cancer Survivors

Smita Bhatia, MD, MPH

Cellular and Molecular Basis of the Neurological Effects of Chemotherapy

James Bibb, PhD and Etty (Tika) Benveniste, PhD

FAM129B/NIBAN2 as a biomarker for therapy with NRF2 inhibitors

Anindya Dutta, MD, PhD

Targeting CSF1R/PU.1 signaling and PU.1 super-enhancer regulation in tumor progression across breast cancer subtypes

Blake Eason Hildreth, III, DVM, MS, PhD

Phase II single arm trial of low dose capecitabine in patients with advanced breast cancer

Katia Khoury, MD

Hijacking axonogenesis to promote breast cancer by a subset of regulatory T cells

Jianmei Leavenworth, MD, PhD

Research Support for Breast Surgical Fellow

Catherine Parker, MD

Elucidating the effects of hypoxia on ribosome biogenesis in breast cancer

Dr. Amr Rafat

Unique Arteriolar Niche in Expansion of Breast Cancer Stem Cells for Metastasis

Bin Ren, MD, PhD

Identification of HIF-1a interactors in the nucleolus of breast cancer cells

Rajeev Samant, PhD

A novel clinically actionable approach to disable resurgence and metastasis of triple-negative breast cancer

Lalita Shevde-Samant, PhD

Intercellular Mitochondrial Trafficking as a Novel Mechanism in Breast Cancer Progression and Metastasis

Keshav Singh, PhD

Developing novel AKT degrader to selectively inhibit the growth of PI3K/AKT/PTEN pathway mutant breast cancer

Jia Xu, PhD

RNF2 ablation stimulates durable NK-CD4+ T cell-dependent anti-tumor immunity

Eddy Yang, MD, PhD and Zhuo Zhang, MD, PhD

Chronic stress-regulated tumor-neuroimmune network in triple-negative breast cancer

Chao Zhang, MD, PhD

Getting the right treatment to the right patient by matching regimens to patient biopsy before treatment

Karim I. Budhwani, PhD, DLA and Chelsea Crawford, PhD

WNK1, A Novel Regulator of Metastatic Breast Cancer

Dr. Debanjan Chakroborty

Contribution of PERK+ Polyploid Giant Cancer Cells in the Ethnic Disparity of Triple Negative Breast Cancer

Dr. Luis del Pozo-Yauner

Influence of stress on immune landscape and spatial heterogeneity of breast cancer

Dr. Seema Singh

Highly Active Liposomal Formulation of Proteasome Inhibitor Carfilzomib for the Treatment of TNBC

Dr. Alexei F. Kisselev

Cancer genomic study to characterize genetic and epigenetic diversity of immune landscape in triple negative breast cancer in women of African ethnicity

Dr. Deepa Bedi

Inherited Breast Cancer Risk Screening and Education – Historically Black Colleges and Universities Expansion

Dr. Sara Cooper

Carrier-free Quercetin Nanoparticles for Overcoming Breast Cancer Drug Resistance

Dr. Yuping Bao (University of Alabama) and Robert D. Arnold (Auburn University)